Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

While some years back, dogs suffering from disk disease (a condition where herniated disks in the neck or back put pressure on nerves) were given only two options, expensive surgery or euthanasia, ...

Early diagnosis and treatment can slow RA progression ... American College of Rheumatology. Rheumatoid arthritis. Merck Manual. Introduction to the biology of the musculoskeletal system. Johns Hopkins ...

The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...

Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and long-term management of patients with Kawasaki Disease, according to a new ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

a BTK inhibitor with potential as an oral therapy for relapsing multiple sclerosis. Both are heading for key phase 3 readouts next year. Those two drugs are billed as Merck 'wave 2' medicines ...

Head and neck diseases contain tumors, infections, inflammation, and other lesions. These diseases often involve tissues in the mouth, throat, larynx, nasal cavity, paranasal sinuses, ears, and neck.

If you’re on the fence about investing in Eli Lilly and Company, Merck & Co. or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

Dividend stocks offer long-term investors unique benefits.